Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas.
| Autor: | Ting-Yuan Lan1, Yen-Chun Lin2, Tai-Chung Tseng3,4,5, Hung-Chih Yang3, Jui-Hung Kao2, Chiao-Feng Cheng2, Tai-Ju Lee6, Shang-Chin Huang7, Cheng-Hsun Lu6, Ko-Jen Li6, Song-Chou Hsieh6 hsiehsc@ntu.edu.tw |
|---|---|
| Zdroj: | Gut & Liver. Mar2023, Vol. 17 Issue 2, p288-298. 11p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|